BIOMAT Database Logo BIOMAT Database Logo

Anthracycline metabolites from Streptomyces violaceus A262. IV. New anthracycline yellamycins produced by a variant strain SC-7. 1991

O Johdo, and H Tone, and R Okamoto, and A Yoshimoto, and H Naganawa, and T Sawa, and T Takeuchi
Central Research Laboratories, Mercian Corporation, Fujisawa, Japan.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D012334 RNA, Neoplasm RNA present in neoplastic tissue. Neoplasm RNA
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

O Johdo, and H Tone, and R Okamoto, and A Yoshimoto, and H Naganawa, and T Sawa, and T Takeuchi
Anthracycline metabolites from Streptomyces violaceus A262. III. New anthracycline obelmycins produced by a variant strain SE2-2385.
October 1991, The Journal of antibiotics,
O Johdo, and H Tone, and R Okamoto, and A Yoshimoto, and H Naganawa, and T Sawa, and T Takeuchi
Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730.
October 1991, The Journal of antibiotics,
O Johdo, and H Tone, and R Okamoto, and A Yoshimoto, and H Naganawa, and T Sawa, and T Takeuchi
Anthracycline metabolites from Streptomyces violaceus A262. I. Isolation of antibiotic-blocked mutants from Streptomyces violaceus A262.
October 1991, The Journal of antibiotics,
O Johdo, and H Tone, and R Okamoto, and A Yoshimoto, and H Naganawa, and T Sawa, and T Takeuchi
New rhodomycin analogs, SS-288A and SS-288B, produced by a Streptomyces violaceus A262 mutant.
January 1995, Bioscience, biotechnology, and biochemistry,
O Johdo, and H Tone, and R Okamoto, and A Yoshimoto, and H Naganawa, and T Sawa, and T Takeuchi
Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. II. New anthracycline metabolites produced by a blocked mutant strain RPM-5.
January 1993, The Journal of antibiotics,
O Johdo, and H Tone, and R Okamoto, and A Yoshimoto, and H Naganawa, and T Sawa, and T Takeuchi
Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. III. New anthracycline metabolites produced by blocked mutants 4L-660 and YDK-18.
November 1993, The Journal of antibiotics,
O Johdo, and H Tone, and R Okamoto, and A Yoshimoto, and H Naganawa, and T Sawa, and T Takeuchi
New anthracycline antibiotics produced by interspecific recombinants of streptomycetes. I. Selection of Streptomyces violaceus subsp. iremyceticus, an iremycin-producing subspecies.
January 1980, Zeitschrift fur allgemeine Mikrobiologie,
O Johdo, and H Tone, and R Okamoto, and A Yoshimoto, and H Naganawa, and T Sawa, and T Takeuchi
New anthracycline metabolites produced by the aklavinone 11-hydroxylase gene in Streptomyces galilaeus ATCC 31133.
April 1996, The Journal of antibiotics,
O Johdo, and H Tone, and R Okamoto, and A Yoshimoto, and H Naganawa, and T Sawa, and T Takeuchi
Cytotoxic Anthracycline Metabolites from a Recombinant Streptomyces.
May 2018, Journal of natural products,
O Johdo, and H Tone, and R Okamoto, and A Yoshimoto, and H Naganawa, and T Sawa, and T Takeuchi
Further minor metabolites of staurosporine produced by a Streptomyces longisporoflavus strain.
June 1996, The Journal of antibiotics,
Copied contents to your clipboard!